➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Moodys
Baxter
Dow
McKinsey

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GADOBENATE DIMEGLUMINE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for gadobenate dimeglumine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00323310 Safety and Efficacy of MultiHance in Pediatric Patients Terminated Bracco Diagnostics, Inc Phase 3 2006-04-01 The purpose of this study was to assess the safety and enhancing properties of the magnetic resonance imaging (MRI) contrast agent MultiHance in children aged 2 to 17 years having central nervous system (CNS) disorders.
NCT01165892 Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar) Completed Lantheus Medical Imaging N/A 2011-07-01 The use of the contrast agent, Ablavar, will help with the diagnosis of pulmonary embolism in magnetic resonance imaging (MRI).
NCT01165892 Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar) Completed Washington University School of Medicine N/A 2011-07-01 The use of the contrast agent, Ablavar, will help with the diagnosis of pulmonary embolism in magnetic resonance imaging (MRI).
NCT01260636 Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries Completed Bracco Diagnostics, Inc Phase 3 2009-09-01 To compare two gadolinium contrast agents in terms of global paired diagnostic preference (primary endpoint) for the assessment of contrast-enhanced MR Angiography of the carotid, renal/abdominal and peripheral arteries
NCT02226666 Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration Active, not recruiting University of Michigan N/A 2013-08-01 The purpose of this study is to prospectively compare the physiologic response of patients who receive either intravenous gadoxetic acid (Eovist) or intravenous gadobenate dimeglumine (MultiHance).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for gadobenate dimeglumine

Condition Name

Condition Name for gadobenate dimeglumine
Intervention Trials
Adult Brain Stem Glioma 1
Motor Function 1
Breast Cancer 1
Adult Glioblastoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for gadobenate dimeglumine
Intervention Trials
Central Nervous System Diseases 2
Brain Neoplasms 2
Nervous System Diseases 2
Nervous System Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for gadobenate dimeglumine

Trials by Country

Trials by Country for gadobenate dimeglumine
Location Trials
United States 7
Czech Republic 1
Korea, Republic of 1
Belgium 1
Italy 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for gadobenate dimeglumine
Location Trials
California 2
Michigan 2
Wisconsin 1
New Jersey 1
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for gadobenate dimeglumine

Clinical Trial Phase

Clinical Trial Phase for gadobenate dimeglumine
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
Phase 2 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for gadobenate dimeglumine
Clinical Trial Phase Trials
Completed 3
Not yet recruiting 3
Recruiting 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for gadobenate dimeglumine

Sponsor Name

Sponsor Name for gadobenate dimeglumine
Sponsor Trials
Bracco Diagnostics, Inc 3
National Cancer Institute (NCI) 3
Guerbet 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for gadobenate dimeglumine
Sponsor Trials
Other 10
Industry 6
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
AstraZeneca
Colorcon
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.